Goldfarb Gross Seligman & Co. has broad exposure to the life sciences and healthcare industry, having maintained a key role in large M&A transactions, among them a $671m going private transaction for a major pharmaceutical company, as well as handling complex regulatory and licensing matters. Head of life sciences Hili Cohen is a key adviser to technology-based companies in the life sciences, medical devices, pharmaceuticals, digital health, telemedicine, diagnostics, and medical cannabis sectors. Corporate and commercial partner Danny Kleinhendler, emerging talent Shir Shalev, and Ofir Goldstein, who handles technology licensing agreements, investments, capital, and development agreements, are the standout practitioners in a diverse, multidisciplinary team.
Legal 500 Editorial commentary
- Profile
Key clients
- 3 Millenium Group
- Abbott Laboratories
- Accelmed
- Acthera Therapeutics Ltd.
- Agada Medical Ltd.
- AISAP
- AIVF
- Align Technology, Ltd
- Almeda Ventures Limited Partnership
- American Well
Work highlights
Representing medical device company Magenta Medical in its USD105m Series E financing round.
- Representing the Special Committee of the Board of Directors of Taro Pharmaceutical Industries Ltd. in its USD671m going private transaction by merger with its controlling shareholder, SUN PHARMA Pharmaceutical Industries Limited.
- Representing Israeli biomed company CartiHeal in its acquisition by international medical device company Smith+Nephew plc for up to USD330m, the largest "exit" in the Israeli biomed field in 2023.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Hili Cohen
Other key lawyers
Ofir Goldstein; Shir Shalev; Danny Kleinhendler